A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the highest dose of the drug (BMS-690514)
that can be safely given to patients with advanced cancer.